Author Interviews, Cannabis, McGill, Rheumatology / 04.03.2014

Mary-Ann Fitzcharles, MB, ChB, MRCP(UK), FRCP(C) McGill University Health Centre Division of Rheumatology and Alan Edwards Pain Management UnitMedicalResearch.com Interview with: Mary-Ann Fitzcharles, MB, ChB, MRCP(UK), FRCP(C) McGill University Health Centre Division of Rheumatology and Alan Edwards Pain Management Unit MedicalResearch.com: What are the highlights of your review? Dr. Fitzcharles: Thank you for your interest in the review article which will shortly be published in Arthritis Care & Research. This was not a research study but rather a review focused towards the use of herbal cannabis for patients with rheumatic diseases. The essence of our message after a thorough review of the literature is that there is not a single study published regarding efficacy or side effects of herbal cannabis in the rheumatic diseases. It is notable that almost 2 thirds of persons using herbal cannabis for therapeutic reasons report use for musculoskeletal complaints. In the 21st century, we cannot rely upon heresay or anecdote to justify use of a treatment intervention. It is unacceptable to recommend use of a substance without knowledge of concentration of molecules in the product, any knowledge of blood concentrations that might have a positive or negative effect, and formal study in defined patient populations with acceptable endpoint criteria and evidence for short and long term risks. (more…)
Author Interviews, Pain Research, Rheumatology, Sleep Disorders / 14.02.2014

dr_john_mcbethMedicalResearch.com Interview: Dr. John McBeth Arthritis Research UK Primary Care Centre Keele University in Staffordshire MedicalResearch.com: What are the main findings of the study? Dr. McBeth: In this study, reporting musculoskeletal pain was common with just under half of participants reporting some pain and one quarter reporting widespread pain. Of those who were free of WP at baseline, 19% reported new onset widespread pain at three year follow up. In addition to osteoarthritis, sleep, cognitive impairment, anxiety and physical health independently predicted the onset of widespread pain and are important treatment targets. In this study non-restorative sleep was the strongest predictor of new onset widespread pain. Sleep is a modifiable target that could improve outcome in this patient group. (more…)
Author Interviews, Electronic Records, Rheumatology / 05.02.2014

Gabriela Schmajuk M.D. M.S. Department of Medicine (Rheumatology) University of California, San Francisco San Francisco VA Medical Center San Francisco, CA 94121MedicalResearch.com Interview with: Gabriela Schmajuk M.D. M.S. Department of Medicine (Rheumatology) University of California, San Francisco San Francisco VA Medical Center San Francisco, CA 94121 MedicalResearch.com: What are the main findings of the study? Dr. Schmajuk: Our main findings were that moderate LFT abnormalities were uncommon in the first 7 months of methotrexate use among new users, and more likely to occur in patients with obesity, untreated high cholesterol, pre-methotrexate LFT elevations, biologic agent use, and lack of folic acid supplementation. (more…)
Author Interviews, Exercise - Fitness, Rheumatology / 02.02.2014

MedicalResearch.com Interview with: Carsten Juhl, PhD, MPH Research Physiotherapist Forskningsenheden for Muskuloskeletal Funktion og Fysioterapi (FoF) Institut for idræt og biomekanik Syddansk Universitet MedicalResearch.com: What are the main findings of the study? Dr. Juhi:  The main findings of this study including 48 RCTs with more than 4000 patients were that
  • [1] exercise therapy programs focusing on a single type of exercise were more efficacious in reducing pain and patient-reported disability than those mixing several types of exercise with different goals within the same session;
  • [2] the number of supervised sessions enhances the benefits of the aerobic exercise;
  • [3] exercise focusing on the knee extensor muscle strength only, may increase the benefits of resistance training and
  • [4] exercise seems to be effective therapy for knee osteoarthritis, regardless of age, sex, BMI, radiographic status or baseline pain.
(more…)
Author Interviews, Heart Disease, Rheumatology / 18.12.2013

MedicalResearch.com Interview with: M Mushfiqur Rahman, MSc. PhD candidate School of Population and Public Health University of British Columbia, Statistical Analyst Arthritis Research Centre of Canada 5591 No. 3 Road, Richmond BC, Canada, V6X 2C7; MedicalResearch.com:  What are the main findings of the study? Author’s response: Using 18 years of administrative health records from British Columbia, Canada, our aim was to determine whether osteoarthritis increases the risk of cardiovascular disease in a longitudinal study. We also examined the risks of specific cardiovascular conditions such as, myocardial infarction, ischemic heart disease, congestive heart failure, and stroke after adjusting for age, sex, socio-economic status, diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease, and a co-morbidity score. We observed a significant increase in the risk of cardiovascular disease, ischemic heart disease, and congestive heart failure among individuals with osteoarthritis compared with age-sex matched non-osteoarthritis individuals. Our data suggests that adult women and men aged 65 years and older with osteoarthritis had higher risks of developing these conditions. The risks were also higher among severe osteoarthritis patients who had undergone total joint replacement surgeries. Men aged between 20-64 years with osteoarthritis did not show higher risks of developing these conditions. (more…)
Author Interviews, Rheumatology / 02.11.2013

Dr. Laura Coates Division of Rheumatic and Musculoskeletal Disease Chapel Allerton Hospital Chapeltown Road Leeds NIHR Clinical Lecturer at the University of LeedsMedicalResearch.com Interview with: Dr. Laura Coates Division of Rheumatic and Musculoskeletal Disease Chapel Allerton Hospital Chapeltown Road Leeds NIHR Clinical Lecturer at the University of Leeds
MedicalResearch.com: What are the main findings of the study? Answer: The TICOPA study showed that treating patients with early psoriatic arthritis to an objective target with regular review improved patient's clinical outcome both in terms of arthritis and skin psoriasis.  There was an increase in adverse events in the tight control arm but only 4 serious infections seen in the tight control arm that were thought to be related to treatment (2 cases of cellulitis, 2 cases of chest infection). (more…)
Author Interviews, Heart Disease, Mayo Clinic, Rheumatology / 30.10.2013

Eric Matteson, M.D. Rheumatology Chair Mayo Clinic in Rochester, Minn.MedicalResearch.com Interview with: Eric Matteson, M.D. Rheumatology Chair Mayo Clinic in Rochester, Minn. MedicalResearch.com:   What are the main findings of the studies? Dr. Matteson: “The main finding is that patients with severe rheumatoid arthritis have a higher risk of heart disease.  Further, women who experience early menopause also have a higher risk of heart disease.” (more…)
Author Interviews, Heart Disease, Rheumatology / 29.10.2013

MedicalResearch.com Interview with: Lotta Ljung, MD, PhD Umeå University, Umeå and Karolinska  Institute Stockholm, Sweden MedicalResearch.com: What are the main findings of the study? Dr. Ljung:  In this observational study we observed a lower risk of acute coronary syndromes in a cohort of patients with rheumatoid arthritis (RA) exposed to tumor necrosis factor inhibitors (TNFi) compared with the risk among patients without this exposure. The adjusted relative risk (HR) was 0.73-0.82  among TNFi exposed patients compared with the biologics-naive RA cohort, depending on the time frame evaluated, which can be concluded as a moderately lower risk. Compared with the risk in the general population, the risk in RA patients was higher, whether exposed to TNFi or not. (more…)
Author Interviews, BMJ, Rheumatology / 03.10.2013

MedicalResearch.com Interview with A/Prof Susanna M Proudman MB BS (Hons) FRACP Discipline of Medicine, University of Adelaide Senior Consultant in Rheumatology Royal Adelaide Hospital North Terrace, Adelaide, 5000 MedicalResearch.com: What are the main findings of the study? Answer: In patients with early DMARD-naïve rheumatoid arthritis (RA), fish oil (delivering an average daily dose of 3.7 g dose of omega-3 fats) was associated with benefits additional to those achieved by combination treat-to-target DMARDs with similar methotrexate use. These included significantly reduced risk of triple DMARD failure, defined as needing the addition of leflunomide, and a higher rate of ACR remission. Because a structured treatment algorithm that was responsive to disease activity and tolerance was used, drug use could be used as an outcome measure for the effects of fish oil. This is one of the novel features of this study as the study design allows for a RCT to be performed on a background of treat-to-target therapy for early RA. (more…)
Author Interviews, BMJ, Outcomes & Safety, Rheumatology / 30.08.2013

MedicalResearch.com Interview with: Mwidimi Ndosi, PhD, MSc, BSc (Hons), RN. Academic & Clinical Unit for Musculoskeletal Nursing (ACUMeN) Leeds Institute of Rheumatic and Musculoskeletal Medicine University of Leeds England MedicalResearch.com: What are the main findings of the study? Answer: The aims of this study was to determine the clinical and cost-effectiveness of nurse-led care for people with rheumatoid arthritis. The main findings were: (i)             Patients seeing clinical nurse specialists for their rheumatoid arthritis follow-up care do not get an inferior treatment. (ii)           Nurse-led care is safe and in some aspects presents added value to patients (iii)          Nurse-led care represents good value for money in terms of disease management for people with RA. (more…)
Author Interviews, BMJ, Case Western, Rheumatology / 29.08.2013

Dr Janet E Pope Division of Rheumatology, Department of Medicine The University of Western Ontario, St Joseph's Health Centre 268 Grosvenor Street, London, ON, Canada N6A 4V2MedicalResearch.com Interview with: Dr. Janet E Pope Division of Rheumatology, Department of Medicine The University of Western Ontario, St Joseph's Health Centre 268 Grosvenor Street, London, ON, Canada N6A 4V2   MedicalResearch.com: What are the main findings of the study?  Dr. Pope: We performed a RCT of patients who were stable for 6 months of etanercept added to methotrexate (inadequate responders to Mtx) who were randomized to stopping Mtx or continuing Mtx to determine if in the next 6 months (and later as the trial continues) the response rate would be the same if Mtx was discontinued. Overall, Mtx + etanercept was not statistically equivalent to etanercept alone (ie non-inferiority did not occur); implying 6 months after stopping Mtx, the etanercept patients on monotherapy performed slightly less well than those on combination therapy. (more…)
Author Interviews, JAMA, Rheumatology / 22.08.2013

MedicalResearch.com Interview with: Matthew Parkes Research Statistician Research in Osteoarthritis Manchester (ROAM) Arthritis Research UK Epidemiology Unit Centre for Musculoskeletal Research Institute of Inflammation and Repair The University of Manchester Manchester Academic Health Science Centre Manchester M13 9PT MedicalResearch.com: What are the main findings of the study? Answer: Looking at all trials of lateral wedge insoles, they seem to reduce pain slightly. However, looking at trials which compare lateral wedges to flat wedges, they don’t appear to differ in terms of pain reduction. (more…)
Author Interviews, Fish, General Medicine, Rheumatology / 16.08.2013

MedicalResearch.com Interview with: Daniela Di Giuseppe Division of Nutritional Epidemiology Institute of Environmental Medicine Karolinska Institutet Stockholm 171 77, Sweden MedicalResearch.com: What are the main findings of the study? Answer: Women whose long-term intake of omega 3 PUFAs exceeded 0.21 g a day, equivalent to at least one serving of fatty fish or four servings of lean fish a week, had half the risk (52% lower) of rheumatoid arthritis of women who consumed less. (more…)
JAMA, Rheumatology / 04.07.2013

MedicalResearch.com Interview with: Jonas Eriksson, PhD-student Clinical Epidemiology Unit Karolinska Institutet, T2 171 76 STOCKHOLM Sweden Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid Arthritis A Randomized Trial MedicalResearch.com:  What are the main findings of the study? Answer: The main finding from this study is that in patients with early rheumatoid arthritis and with an insufficient response to methotrexate, addition of biologic (infliximab) or conventional combination therapy (sulfasalazine+hydroxychlorquine) resulted in significant improvements in work ability over 21 months. However, at 21 months, no significant difference could be detected in work ability change between patients randomized to addition of biologic or conventional therapy. When comparing the randomized early rheumatoid arthritis patients to matched general population comparators, the average number of days of work loss did not return to the level of the general population, underscoring the need for more effective treatment strategies and earlier diagnosis. (more…)
Author Interviews, JAMA, Pediatrics, Rheumatology, Vaccine Studies / 19.06.2013

Marloes Heijstek MD University Medical Center, Wilhelmina Children's Hospital Department of Pediatric Immunology and Rheumatology Room number KC 03.063.0 P.O. Box 85090 Lundlaan 6 3508 AB UtrechtMedicalResearch.com Interview with: Marloes Heijstek MD University Medical Center, Wilhelmina Children's Hospital Department of Pediatric Immunology and Rheumatology Room number KC 03.063.0 P.O. Box 85090 Lundlaan 6 3508 AB Utrecht MedicalResearch.com: What are the main findings of the study? Dr. Heijstek: The main findings of our study are that MMR booster vaccination does not affect JIA disease, does not cause flares of arthritis and induces high rates of protective immunity. (more…)